Member Info for English_Parisien

All ramping aside ... What are our chances of breaking a penny next week should the Calidus news be as postitive as we hope ?

Do remember that we are to a degree dependant upon what happens with Sarepta too ... though what that event(s) might be and when is beyond my crystal ball abilities ... - EP

The real question is ... assuming very positive news from Caldius, how much will this move realistically ? And will it hold or retarce? The longer term picture here remains Q3 2018, if my notes are correct ... (And of course, Togo remains a long long term strategy) If we could break a penny on good news, that would be something! And a personal reason to top up ... 2p is a long way away currently to get back in black! Good luck with whatever your strategy may be - EP

If only you knew the half of it ... I have a little way yet to go but fingers crossed. Probably more towards Q3 for DMD but who knows? As for C.Diff, it's a shame it cannot be fast-tracked from Phase II (as might well be the case for DMD and Orphan Drug Status). I cannot imagine how it must feel for those waiting to benefit from these potential medicines. 3 years is an awfully long time, but I understood completely why such thorough, rigorous processes are the way they are. GLA - EP

Thanks for the clarification F-M! Wish I hadn't been so caught up in work these last few weeks. Missed an opportunity to reduce holding SP in VAL in November ... would now be sitting in profit and not loss. All the more reason to cross fingers and toes for SUMM! ATB - EP

Such detail was missing from KRS' presentation. Thank you Andee - EP

Boys & girls: next planned news currently is the Q1 DMD Phase II test read outs yes? Unless extra P3 funding comes in or something changes (sarepta, licensing, other...) ... Just making sure I haven’t missed anything Trying to anticipate the potential for my H1 2018 (SUMM / SAR / VAL) Thank you Have a good week ATB - EP

Fair enough Dependent upon Trump's impeachment also! Going back to KRS though, the PFS potential announcement, according to the company presentation, is at the earliest, H2 2018 ... still 6 months for the SP to rise/fall between now and then My strategy will be to top-up elsewhere, where long-awaited news is expected in the next 6 months and then use funds (should I make any, fingers crossed) to drastically reduce my average here. Thanks for the help GLA, have a good week - EP

Should we make it to £2, I will a) have balls of steel to have held that long (which I then might alloy with gold) and b) will have far more money than I will know what to do with ... I had a quick look at the numbers ... it will take a lot of crises and luck to get to the 5000+ figures but never say never. Thanks for the feedback. Having a quick read through the RNSs...i have been too focused on work these last few months... @Andee : when are these results due please, should I wish to throw in some extra cash ?

Averaging just shy of 2p here ... what you reckon people? Possibility to break even in 2018? Or is Ferrex (showing my age) one for the sock drawer? Thanks in advance ATB - EP

Afternoon all Keep those fingers and toes crossed. Data presentations from VAL, SAR and SUMM in the weeks and months. For me, this is either going to end up very green come Easter or I am going to be very, very miserable! We make our own beds by investing ... Would be nice to finally see these companies advancing their compounds, helping those who need it and in doing so, turning a profit for us LTHs. All going to plan here it would seem. Thanks for the update Gerry Hello from London! Back to Paris Friday ATB - EP

2020/2021 feels like an awfully long way away ...

And what do you make of those that went through on the 2nd Oct?

Looks like a rollover ... £285K

Hello AMM I want to believe everything you have just said. I am just adding a nuanced view simply because I don't want to over exaggerate what might occur on the production of the data we hoped. I have seen the "SAR effect" a few years back and how the SP erupted beyond anyone's expectations. And also I simply not qualified enough to make an educated guess .. so I would prefer a nice surprise rather than disappointment. Should we soar far and beyond £3, it will be because the data is THAT good, which is first and foremost promising for the families affected. And then it will be a pleasant result for us :) Don't get me wrong, I hold and believe and will advocate this to anyone wanting to invest. ATB - EP

I'm more hoping (greedily) for £5-£10 If everything gets sured up with DMD in Q1, I would like to think that this will automatically move into the £3+ range From which, who knows ... a JV, T/O, other and then hello £5+ People here have different holdings and aims as you said ... I need £7 to hit 6-figures, and whilst I would love to double my holding, put all my eggs into the SUMM basket and pray to AIM deities ... I don't trust AIM enough to deliver. Making a nice return here would also cancel out my red elsewhere ... On an aside, you still in Keras Gerry? Thoughts there ... And anyone in the dog of a share otherwise known as VAL ? All the best -EP

Oh dear. It was all too good to be true. The science still remains (!) but my naivety got the better of me and I thought we might be finally onto something good, financially speaking. I shall continue to hold and see what happens in run up to results, as expressed by others below. But a Father Jack-esque rant comes to find just now ... -EP

Perhaps ... but it's the second week of September ... long way to go before the end of the year! ;-)

Come on kids, play nice. Give Pom the benefit of the doubt or devil's advocate, call it what you will. Until we have the rest of the non-dilutive funding in place, his statement cannot be confirmed or refuted. However, we all seem to be approaching the same page: there is interest in RDZ. The question now is "how much?" and I mean that in both the feeling and monetary sense! I am disappointed that the SP is already dropping ... had hoped from a somewhat more buoyant reaction other than the spike on Monday. In the mean time, I shall continue to hold and hope that Summit will be the shining light and good example for a successful AIM stock amongst the rest of my portfolio which is notably less green! GLA - EP

This is also how I understood it. Any new creation linked to RDZ from this moment forth. However the phrase "entitled to" is deliberately vague and implies "should" rather than "must". Am currently unaware of any second generation RDZ drugs. And as per the text below, SUMMIT has full rights to the US market for the current drug. And with a 3-way focus between CDIFF, DMD Gen1 and DMD Gen2&beyond ... I think Summit have their work cut out for now and that there should be no cause for alarm or reading too much into the text NEVERTHELESS ... good research Gerry! - EP